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Australians' use of the English language is influenced by a British educational 
curriculum, exposure to international television programmes and cultural 
backgrounds. Hence, adapting research instruments for use with Australian 
populations can be challenging. This study adapted the United Kingdom's version 
of the 20-item Diabetes Management Self-Efficacy Scale and tested it 
psychometrically with Australians. Face validity of the adapted instrument was 
established through consultation with diabetes educators and people with type 2 
diabetes. Data from a convenience sample of 88 people with type 2 diabetes were 
analysed to determine the psychometric properties of the adapted instrument. The 
results indicate that the Australian/English version of the instrument is 
internally consistent, stable over time and it measures self-efficacy. However, 
there was evidence to show that there might be some redundant items in the 
scale. Further psychometric testing is warranted with a larger sample to 
determine whether the scale requires refinement. 
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Chronic diseases are reaching near-epidemic proportions in the developed world. 
This is attributed to factors such as an ageing population and poor lifestyle 
behaviours. Diabetes is the fastest-growing chronic disease of all, and is 
rapidly becoming a major health issue. More than one million Australians have 
diabetes and this figure is projected to rise to 1.7 million by 2030.1 The 
majority (8590%) of these people have type 2 diabetes.2 People with type 2 
diabetes are vulnerable to serious complications, including blindness, lower 
limb amputation, renal and cardiac disease and, as a result, are twice as likely 
to be admitted to hospital as the general population.2 It is estimated that the 
direct cost of treating diabetes and its related complications in Australia is 
almost $A1 billion per annum.3 Thus, reducing the risk of complications is 
vitally important, not only from a personal, but also, an economic perspective. 
 
Many complications arising from type 2 diabetes are preventable if rigorous 
attention is paid to managing the disease. Management includes following a 
prescribed medication regime, monitoring diet and blood glucose levels, doing 
physical activities, and caring for feet. All of these tasks need to be 
incorporated into daily living. Therefore, people who are newly diagnosed with 
the disease require education and assistance to learn the skills that are 
relevant to the management of their illness. This is particularly important for 
older people as they are often at greater risk of complications because of 
comorbidities.4,5 Adequate management of type 2 diabetes can be difficult to 
achieve and maintain as people age, however, because of long-established 
patterns of health behaviour.6,7 Thus, addressing the task-related issues of 
self-managing diabetes in an environment that fosters behavioural change towards 
personal health care is vital. 
 
A factor considered to be particularly important to the process of changing 
self-care behaviour and personal health outcomes is self-efficacy.8,9 The 
concept of self-efficacy, derived from socialcognitive theory,10 is one in which 
the behaviour of a person, that person's characteristics and the environment in 
which the behaviour occurs are constantly interacting. Therefore, a change in 
one of these factors impacts on the other two. Thus, behavioural, cognitive and 
social skills must be organized and integrated if a person is to undertake 
action. A mediating factor in the model is 'efficacy-expectations'. Four 
significant sources of information influence efficacy-expectations. These are: 
(i) performance accomplishment (practising and experiencing success in achieving 
goals); (ii) vicarious experience (observing others perform tasks successfully); 
(iii) verbal persuasion (receiving positive verbal reinforcement from others); 
and (iv) self-appraisal (monitoring information about the physical and emotional 
effects of a specific situation). All influence an individual's efficacy-
expectations that, in turn, influence behaviour, which predicts a particular 
outcome.1012 
 
Self-efficacy is conceptualized by scholars as a global and a domain-specific 
construct. Those who favour the global model argue that it is an underlying 
broad sense of personal control that influences decision-making when dealing 
with challenging situations. Hence, people with a high level of generalized 
self-efficacy deal more effectively with adversity than those who do not.13,14 
The proponents of the global model also acknowledge the widely held view that 
self-efficacy is domain-specific.10 That is, a person might be self-efficacious 
towards one particular action (e.g. writing a novel) but not another (e.g. 
monitoring blood glucose levels). Thus, it is the domain-specific model of self-
efficacy that is most suited to underpinning educational interventions aimed at 
enhancing self-management of type 2 diabetes. 
 
The authors are collaborating with a larger group of researchers, the 
International Partners in Self-management and Empowerment (IPSE), to undertake a 
multinational programme of research, supported by self-efficacy theory, which is 
aimed at achieving global improvement in self-management of type 2 diabetes. The 
first stage in the programme involves constructing and validating instruments 
that measure components of a diabetes-specific self-efficacy model. One of these 
instruments is the Diabetes Management Self-Efficacy Scale (DMSES), which 
measures efficacy-expectations towards diabetes self-care activities. Originally 
developed by IPSE partners in The Netherlands,15 the DMSES is being adapted and 
validated by IPSE researchers at six sites in five countries (Australia, 
Belgium, Switzerland, United Kingdom (UK) and United States of America (USA)) 
for use in the second stage of the research programme. This next stage will 
develop, implement and evaluate a suite of culturally specific educational 
interventions. 
 
 
In Australia, the authors adapted the DMSES from the original UK/English version 
of the instrument developed by Hearnshaw and Sturt (unpubl. data, 2002). The 
original UK/English version comprises 20 items that assess the extent to which 
respondents are confident that they can manage their blood glucose level, foot 
care, medication, diet and level of physical activity. Responses are rated on an 
11-point scale anchored with 'Cannot do at all' (0), 'Maybe yes/maybe no' (5) 
and 'Certain can do' (10). Responses are summed to produce a single score for 
self-efficacy. Possible scores range from 0200, with higher scores indicating 
greater self-efficacy. To date, versions of the DMSES have demonstrated 
acceptable reliability and validity in Dutch,15 USA16 and UK (Sturt and 
Hearnshaw, unpubl. data, 2004) populations. This paper describes the adaptation 
process and preliminary validation of the Australian/English version of the 
DMSES. 
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A two-phased study was undertaken to validate the DMSES for use with Australian 
populations. Phase I adapted the instrument to the Australian context and 
vernacular and, in so doing, established face validity. Phase II tested the 
reliability and validity of the instrument psychometrically. The protocol for 
the study was approved by the Queensland University of Technology Human Research 
Ethics Committee and the Princess Alexandra Hospital Human Research Ethics 
Committee, and was conducted according to the principles outlined in the 
Declaration of Helsinki.17 
 
Phase I 
 
A convenience sample of 10 diabetes educators, and four patients who met the 
criteria for eligibility, participated in this phase. The eligibility criteria 
for patients were: 
 
  Diagnosed with type 2 diabetes 
  
  Aged  18 years 
  
  Self-administering oral medication to control diabetes 
  
  Not cognitively impaired (as determined by nursing or medical report) 
  
  Able to speak and understand English 
  
 
Senior diabetes educators at four acute-care health institutions in metropolitan 
Brisbane were contacted and invited to participate in the study. Each of these 
educators agreed and undertook to recruit all diabetes educators who worked in 
the relevant institution, plus one eligible patient. Fourteen packages 
containing a questionnaire that incorporated the UK/English version of the DMSES 
items, a letter that informed recipients about the purpose of the study, an 
evaluation form for documenting suggested changes to the layout and wording of 
questionnaire items and a reply paid envelope were prepared and distributed. The 
response rate was 100%. 
 
Participants agreed that the layout of the questionnaire was satisfactory. 
However, as expected, changes to wording so that it better reflected the 
Australian environment and dialect were suggested. The response descriptor 
'Certain can do' was changed to 'Certainly can do'. Three main issues were 
identified with regard to questionnaire items. The most common suggestion was to 
change items that referred to exercise. Australians, in general, do not 'take' 
exercise, they 'do' it, and, increasingly, Australian lifestyle media refer to 
'doing physical activity' rather than 'doing exercise'. The second suggestion of 
note was made by diabetes educators. They expressed concern about the use of the 
words 'adjust' and 'correct', particularly in relation to medication use. In 
Australia, people with type 2 diabetes are educated to maintain their regime, 
which might entail some adjustment in certain situations. It was considered that 
'maintain' was a more appropriate word in this context. Similarly, the most 
appropriate word in Australian English is eating 'plan' rather than eating 
'pattern'. 
 
Two of the authors examined the suggestions and recommended that 14 changes be 
made to the wording of items in the DMSES. These recommendations were accepted 
by the Australian IPSE partners and are presented in Table 1. The revised 
instrument is known as the AUS/English version of the DMSES. 
 
Phase II 
 
One-hundred-and-twenty people who met the eligibility criteria described for 
Phase I were invited to participate in the Phase II study. Sixty-seven people 
were recruited via advertising, and 65 of these returned completed 
questionnaires (97%). A further 53 people were identified via a general medical 
practice. Of these, 25 returned questionnaires (47.2%), giving an overall 
response rate of 75%. Two of the questionnaires were excluded due to substantial 
missing data, leaving a total sample of 88 participants. A convenience sample of 
32 participants from the 'advertising' group was invited to participate in the 
retest of the DMSES, and 93.7% responded (n = 30). The characteristics of the 
participants are presented in Table 2. 
 
Participants were recruited to this study using two methods. The first involved 
placing advertisements in local newspapers, diabetes-related magazines and 
websites, and distributing brochures to support groups and community health 
clinics. Potential participants contacted the investigators and were screened to 
ensure that they met the research criteria. Packages containing further 
information about the study, a questionnaire containing the AUS/English version 
of the DMSES and a reply paid envelope were mailed to eligible participants. At 
three weeks after the first mail-out, non-respondents were telephoned by one of 
the investigators. No further contact was made with non-respondents. In the 
second method, potential participants who met the eligibility criteria were 
identified by a general medical practitioner from his patient list. Packages 
prepared by the investigators, as per the protocol for the first method, were 
addressed and mailed by staff at the practice so as to maintain patient 
confidentiality. 
 
Potential participants in the retest study undertaken as part of Phase II were 
those recruited via advertising who returned the initial questionnaire within 
three weeks. A package containing the AUS/English version of the DMSES, an 
invitation to complete the questionnaire a second time and a reply paid envelope 
were mailed to each of these people at three weeks after the first mail-out. 
This procedure continued until 30 complete questionnaires were received. The 
characteristics of the retest sample were similar to those of the total sample 
(see Table 2). 
 
Data were double-entered for verification using SPSS statistical software (SPSS, 
Chicago, USA) and irregularities were checked with original questionnaires. 
Missing data were replaced with mean values for the relevant variables. 
Statistical analyses were undertaken to determine the response distribution, 
internal consistency, temporal stability and convergent validity of the DMSES. 
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Response distribution 
 
Participants' DMSES scores (n = 88) ranged from 62200. The median score of 168 
indicated that the data were skewed towards higher self-efficacy, and there was 
a ceiling effect of 3.4%. 
 
Internal consistency 
 
The DMSES was examined for internal consistency using all available data (n = 
88). Cronbach's alpha coefficient for the DMSES = 0.91. The mean-item 
correlation = 0.31 (min. = 0.09, max. = 0.96) and the corrected item-total 
correlations ranged from 0.020.78, with all but five items > 0.40. Removal of 
these items (1, 7, 18, 19 and 20) made little difference to the alpha 
coefficient (r = 0.92) but increased the mean-item correlation to 0.46. This 
suggests that the scale might be more cohesive if these five items are 
removed.18 
 
An examination of the inter-item correlation matrix for the 20 items revealed 
five correlation coefficients > 0.80. These were: Items 2 and 3 (r = 0.91); 
Items 8 and 11 (r = 0.83); Items 13 and 14 (r = 0.96); Items 13 and 15 (r = 
0.85); and Items 14 and 15 (r = 0.87). These correlations indicate that there 
might be some redundancy in the scale.19 
 
Temporal stability 
 
A Pearson's correlation coefficient was calculated to determine the strength of 
relationship between responses (n = 30) to the DMSES over time, with three weeks 
between administrations. The result was r = 0.76 (P < 0.001). 
 
Additionally, the level of agreement between responses at both administrations 
was plotted using a method described by Bland and Altman.20 The level of 
agreement for each respondent was within 95% confidence estimates, indicating 
that the DMSES was stable over time. However, the mean difference exceeded zero 
(M = 4.13, SD = 15.5), suggesting that there might be some bias in the data. 
 
Convergent validity 
 
A valid instrument should measure the underlying construct. In this instance, 
the DMSES, although domain-specific, should measure the level of a respondent's 
self-efficacy. In order to examine whether the DMSES is valid in this regard, a 
measure of generalized self-efficacy, the General Self-Efficacy (GSE) scale, was 
administered concurrently with the DMSES to a convenience sample of the 
participants (n = 65). 
 
The GSE is a measure of self-efficacy that was developed in Germany by Schwarzer 
and Jerusalem.21 The scale comprises 10 items that assess a person's self-
efficacy in general situations; for example, 'I can always solve difficult 
problems if I try hard enough' and 'I can handle whatever comes my way'. The 
instrument has been adapted to 28 languages and is reported to be internally 
reliable (alpha coefficients ranging from 0.750.91 across populations from 25 
countries).22 It has also been shown to be reliable and valid when tested for 
convergent and discriminant validity.23 Factor analysis of data from 19 120 
participants indicates that the GSE is unidimensional.22 
 
Responses to the DMSES and GSE scale were correlated to assess the strength of 
relationship. Pearson's correlation between the DMSES and GSE = 0.52 (P < 
0.001), which provides some evidence that the DMSES does measure self-efficacy. 
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The outcomes from this study of the psychometric properties of the AUS/English 
version of the DMSES suggest that the instrument is appropriate for use with 
Australians who have type 2 diabetes. Face validity was achieved by engaging 
with health professionals and patients to ensure that the wording of items in 
the scale were comprehensible to older Australians, whose early education was 
influenced by a British curriculum, as well as younger Australians whose use of 
the English language has been shaped by exposure to American television 
programmes. 
 
The response distribution for mean DMSES scores tended towards the upper end of 
the scale. This trend could be explained by the methodology used to recruit 
participants to the study. The convenience sample was recruited by means of 
advertisements, brochures and a mail-out to people who had no previous contact 
with the researchers. It could be argued that only people who are highly self-
efficacious will respond to this method. However, the ceiling effect was low and 
scores for the scale covered a wide spread, so this is unlikely. 
 
The high alpha coefficient suggests that the scale is internally reliable. It is 
a little higher than that found for the Dutch version of the DMSES15 but similar 
to coefficients reported for the US/English16 and UK/English versions of the 
scale (Sturt, pers. comm., 2003). However, the wide spread of mean-item 
correlations indicates that the scale might not be homogeneous.18 Furthermore, 
as a number of items were highly correlated, there is a suggestion that there is 
some redundancy in the scale.19 Factor analysis undertaken with a larger 
dataset, in conjunction with discussion among the IPSE researchers at the 
international level as to whether the identified items are integral to the 
underlying construct, would be useful. 
 
The outcomes of reliability analyses show that the AUS/English version of the 
DMSES is stable over time, confirming previous analyses of temporal stability in 
other versions of the instrument15 (and Sturt and Hearnshaw, unpubl. data, 
2004). The outcomes revealed a strong relationship between responses at two 
different administration times and a strong level of agreement between 
individual responses over time. There was some suggestion of bias as scores 
tended to be marginally higher at the second administration. This might be 
attributable to previous knowledge of the questionnaire. 
 
To the best of the authors' knowledge, this is the first time that a version of 
the DMSES has been tested for convergent validity. This is not surprising given 
that it is a domain-specific measure of efficacy-expectations and there are few, 
if any, other such instruments specifically designed for use with people who 
have type 2 diabetes. The strength of the relationship between the AUS/English 
version of the DMSES and a measure of generalized self-efficacy provides an 
indication of the instrument's ability to measure underlying self-efficacy. It 
remains to be seen if this evidence is confirmed in other studies. 
 
In conclusion, this paper demonstrates that it cannot be assumed that 
questionnaire items written in English are intelligible to all populations where 
English is the first language. It also reveals that careful selection of 
culturally appropriate wording that is faithful to the underlying structure of 
questionnaire items can produce similar psychometric outcomes when administered 
across culturally diverse populations. The AUS/English version of the DMSES will 
be used in the second stage of the IPSE research programme with Australians who 
have type 2 diabetes. Further psychometric analysis to address the issue of 
potentially redundant items will be undertaken at that time. 
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